Precancerous colorectal lesions (Review)

Conteduca,Vincenza; Sansonno,Domenico; Russi,Sabino; Dammacco,Franco

doi:10.3892/ijo.2013.2041

Precancerous colorectal lesions (Review)

Authors:
- Vincenza Conteduca
- Domenico Sansonno
- Sabino Russi
- Franco Dammacco
View Affiliations

Affiliations: Department of Medical Oncology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola (FC), Italy, Department of Internal Medicine and Clinical Oncology, University of Bari ‘Aldo Moro’, Medical School, Bari, Italy
Published online on: July 29, 2013 https://doi.org/10.3892/ijo.2013.2041
Pages: 973-984

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colorectal cancer (CRC) is a common and often lethal tumor. Over the last 25 years, remarkable progress has been made in understanding its biological and molecular features and in elucidating the steps involved in colon carcinogenesis. This, in turn, has led to a more rational and effective clinical approach to the treatment of CRC. While colorectal adenoma is the most frequent precancerous lesion, other potentially premalignant conditions, including chronic inflammatory bowel diseases and hereditary syndromes, such as familial adenomatous polyposis, Peutz-Jeghers syndrome and juvenile polyposis, involve different sites of the gastrointestinal tract with an overall incidence of less than 5%. In all such cases, disease recognition at an early stage is essential to devise suitable preventive cancer strategies. These topics are addressed in this review, along with the most important epidemiological, pathogenetic and clinical features that lead to malignant transformation. Novel biomarkers for early cancer prediction, detection, prognostic evolution, and the response to treatment are critically assessed as well. Continued improvements in our knowledge of the molecular basis of CRC and the transfer of this information into daily clinical practice will reduce the burden of this disease.

View Figures

View References

1.	American Cancer Society: Colorectal Cancer Facts & Figures 2011–2013. American Cancer Society Inc.; Atlanta, GA: 2011
2.	Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
3.	Conteduca V, Sansonno D, Ingravallo G, Marangi S, Russi S, Lauletta G and Dammacco F: Barrett’s esophagus and esophageal cancer: an overview. Int J Oncol. 41:414–424. 2012.
4.	Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G and Dammacco F: H. pylori infection and gastric cancer: state of the art (Review). Int J Oncol. 42:5–18. 2013.
5.	NCCN Clinical Practice Guidelines in Oncology. Colorectal Cancer screening. 2013.
6.	Levine JS and Ahnen DJ: Adenomatous polyps of the colon. N Engl J Med. 355:2551–2557. 2006. View Article : Google Scholar : PubMed/NCBI
7.	Leggett B and Whitehall V: Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 138:2088–2100. 2010. View Article : Google Scholar : PubMed/NCBI
8.	Fujita K, Yamamoto H, Matsumoto T, et al: Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol. 35:295–304. 2011. View Article : Google Scholar : PubMed/NCBI
9.	Winawer SJ, Zauber AG, Fletcher RH, et al: Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi Society Task Force on colorectal cancer and the American Cancer Society. Gastroenterology. 130:1872–1885. 2006. View Article : Google Scholar
10.	Martínez ME, Baron JA, Lieberman DA, et al: A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 136:832–841. 2009.PubMed/NCBI
11.	Rizzo A, Pallone F, Monteleone G, et al: Intestinal inflammation and colorectal cancer: a double-edged sword? World J Gastroenterol. 17:3092–3100. 2011.PubMed/NCBI
12.	Butterworth AS, Higgins JP and Pharoah P: Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 42:216–227. 2006. View Article : Google Scholar : PubMed/NCBI
13.	Jasperson KW, Tuohy TM, Neklason DW, et al: Hereditary and familial colon cancer. Gastroenterology. 138:2044–2058. 2010. View Article : Google Scholar : PubMed/NCBI
14.	Lynch HT and de la Chapelle A: Hereditary colorectal cancer. N Engl J Med. 348:919–932. 2003. View Article : Google Scholar : PubMed/NCBI
15.	Stoffel E, Mukherjee B, Raymond VM, et al: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 137:1621–1627. 2009. View Article : Google Scholar : PubMed/NCBI
16.	Galiatsatos P and Foulkes WD: Familial adenomatous polyposis. Am J Gastroenterol. 101:385–398. 2006. View Article : Google Scholar
17.	Lubbe SJ, Di Bernardo MC, Chandler IP, et al: Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol. 27:3975–3980. 2009. View Article : Google Scholar : PubMed/NCBI
18.	McGarrity TJ and Amos C: Peutz-Jeghers syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci. 63:2135–2144. 2006. View Article : Google Scholar : PubMed/NCBI
19.	Brosens LA, van Hattem A, Hylind LM, et al: Risk of colorectal cancer in juvenile polyposis. Gut. 56:965–967. 2007. View Article : Google Scholar
20.	Boparai KS, Mathus-Vliegen EM, Koornstra JJ, et al: Increased colorectal cancer risk during follow-up in patients with hyper-plastic polyposis syndrome: a multicentre cohort study. Gut. 59:1098–1100. 2010.PubMed/NCBI
21.	Alexander DD, Weed DL, Cushing CA, et al: Meta-analysis of prospective studies of red meat consumption and colorectal cancer. Eur J Cancer Prev. 20:293–307. 2011. View Article : Google Scholar : PubMed/NCBI
22.	Park JY, Mitrou PN, Dahm CC, et al: Baseline alcohol consumption, type of alcoholic beverage and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition-Norfolk study. Cancer Epidemiol. 33:347–354. 2009. View Article : Google Scholar
23.	Kant P and Hull MA: Excess body weight and obesity - the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol. 8:224–238. 2011. View Article : Google Scholar : PubMed/NCBI
24.	Giouleme O, Diamantidis MD and Katsaros MG: Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol. 17:444–448. 2011. View Article : Google Scholar : PubMed/NCBI
25.	Jin P, Lu XJ, Sheng JQ, et al: Estrogen stimulates the expression of mismatch repair gene hMLH1 in colonic epithelial cells. Cancer Prev Res. 3:910–916. 2010. View Article : Google Scholar : PubMed/NCBI
26.	Ullman TA and Itzkowitz SH: Intestinal inflammation and cancer. Gastroenterology. 140:1807–1816. 2011. View Article : Google Scholar : PubMed/NCBI
27.	Gallimore AM and Godkin A: Epithelial barriers, microbiota, and colorectal cancer. N Engl J Med. 368:32013. View Article : Google Scholar : PubMed/NCBI
28.	Markowitz SD and Bertagnolli MM: Molecular basis of colorectal cancer. N Engl J Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
29.	Pino MS and Chung DC: The chromosomal instability pathway in colon cancer. Gastroenterology. 138:2059–2072. 2010. View Article : Google Scholar : PubMed/NCBI
30.	Hewish M, Lord CJ, Martin SA, et al: Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol. 7:197–208. 2010. View Article : Google Scholar : PubMed/NCBI
31.	Ligtenberg MJ, Kuiper RD, Chan TL, et al: Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet. 41:112–117. 2009.PubMed/NCBI
32.	Pritchard CC and Grady WM: Colorectal cancer molecular biology moves into clinical practice. Gut. 60:116–129. 2011. View Article : Google Scholar : PubMed/NCBI
33.	Weisenberger DJ, Siegmund KD, Campan M, et al: CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 38:787–793. 2006. View Article : Google Scholar
34.	Hinoue T, Weisenberger DJ, Pan F, et al: Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. PLoS One. 4:e83572009. View Article : Google Scholar : PubMed/NCBI
35.	Powell S, Zilz N, Beazer-Barclay Y, et al: APC mutations occur early during colorectal tumorigenesis. Nature. 359:235–237. 1992. View Article : Google Scholar : PubMed/NCBI
36.	Cottrell S, Bicknell D, Kaklamanis L, et al: Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas. Lancet. 340:626–630. 1992. View Article : Google Scholar : PubMed/NCBI
37.	Nieuwenhuis MH and Vasen HF: Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol. 61:153–161. 2007. View Article : Google Scholar : PubMed/NCBI
38.	Rennert G, Almog R, Tomsho LP, et al: Colorectal polyps in carriers of the APC I1307K polymorphism. Dis Colon Rectum. 48:2317–2321. 2005. View Article : Google Scholar : PubMed/NCBI
39.	Kim YS and Deng G: Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia. Gut Liver. 1:1–11. 2007. View Article : Google Scholar : PubMed/NCBI
40.	Goss KH and Groden J: Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol. 18:1967–1979. 2000.PubMed/NCBI
41.	Greenhough A, Smartt HJ, Moore AE, et al: The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
42.	Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
43.	Todaro M, Francipane MG, Medema JP, et al: Colon cancer stem cells: promise of targeted therapy. Gastroenterology. 138:2151–2162. 2010. View Article : Google Scholar : PubMed/NCBI
44.	Zeki SS, Graham TA and Wright NA: Stem cells and their implications for colorectal cancer. Nat Rev Gastroenterol Hepatol. 8:90–100. 2011. View Article : Google Scholar : PubMed/NCBI
45.	Rabeneck L, Paszat LF, Saskin R, et al: Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol. 105:1627–1632. 2010. View Article : Google Scholar : PubMed/NCBI
46.	Levin B, Lieberman DA, McFarland B, et al: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 134:1570–1595. 2008. View Article : Google Scholar
47.	Johnson CD, Chen MH, Toledano AY, et al: Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 359:1207–1217. 2008. View Article : Google Scholar : PubMed/NCBI
48.	Laghi A, Iafrate F, Rengo M, et al: Colorectal cancer screening: The role of CT colonography. World J Gastroenterol. 16:3987–3994. 2010. View Article : Google Scholar : PubMed/NCBI
49.	Pickhardt PJ and Kim DH: Performance of CT colonography for detecting small, diminutive, and flat polyps. Gastrointest Endosc Clin N Am. 20:209–226. 2010. View Article : Google Scholar : PubMed/NCBI
50.	Atkin WS, Edwards R, Kralj-Hans I, et al: Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 375:1624–1633. 2010. View Article : Google Scholar : PubMed/NCBI
51.	Hewitson P, Glasziou P, Watson E, et al: Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 103:1541–1549. 2008. View Article : Google Scholar : PubMed/NCBI
52.	Vasen HF, Watson P, Mecklin JP, et al: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 116:1453–1456. 1999. View Article : Google Scholar
53.	Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 96:261–268. 2004. View Article : Google Scholar
54.	Berg AO, Armstrong K, Botkin J, et al: Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med. 11:35–41. 2009.
55.	Beggs AD, Latchford AR, Vasen HF, et al: Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 59:975–986. 2010. View Article : Google Scholar : PubMed/NCBI
56.	Brosens LA, Langeveld D and van Hattem WA: Juvenile polyposis syndrome. World J Gastroenterol. 17:4839–4844. 2011. View Article : Google Scholar : PubMed/NCBI
57.	Imperiale TF, Ransohoff DF, Itzkowitz SH, et al: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 351:2704–2714. 2004. View Article : Google Scholar : PubMed/NCBI
58.	Ahlquist DA: Next-generation stool DNA testing: expanding the scope. Gastroenterology. 136:2068–2073. 2009. View Article : Google Scholar : PubMed/NCBI
59.	Ahlquist DA, Sargent DJ, Loprinzi CL, et al: Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 149:441–450. 2008. View Article : Google Scholar : PubMed/NCBI
60.	Van Gossum A, Munoz-Navas M, Fernandez-Urien I, et al: Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med. 361:264–270. 2009.
61.	Brenner H MD, Chang-Claude J, Seiler CM, et al: Protection from colorectal cancer after colonoscopy. A population-based, case-control study. Ann Intern Med. 154:22–30. 2011. View Article : Google Scholar : PubMed/NCBI
62.	Ferrara F, Luigiano C, Ghersi S, et al: Efficacy, safety and outcomes of ‘inject and cut’ endoscopic mucosal resection for large sessile and flat colorectal polyps. Digestion. 82:213–220. 2010.
63.	Kirkegaard H, Johnsen NF, Christensen J, et al: Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort study. BMJ. 341:c55042010. View Article : Google Scholar : PubMed/NCBI
64.	Manson JE, Mayne ST and Clinton SK: Vitamin D and prevention of cancer-ready for prime time? N Engl J Med. 364:1385–1387. 2011. View Article : Google Scholar : PubMed/NCBI
65.	Park Y, Spiegelman D, Hunter DJ, et al: Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control. 21:1745–1757. 2010. View Article : Google Scholar : PubMed/NCBI
66.	Kennedy DA, Stern SJ, Moretti M, et al: Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 35:2–10. 2011. View Article : Google Scholar : PubMed/NCBI
67.	Chan AT: Aspirin and familial adenomatous polyposis: coming full circle. Cancer Prev Res (Phila). 4:623–627. 2011. View Article : Google Scholar : PubMed/NCBI
68.	Cole BF, Logan RF, Halabi S, et al: Aspirin for chemoprevention of colorectal adenomas: meta-analysis of the randomised trials. J Natl Cancer Inst. 101:256–266. 2009. View Article : Google Scholar : PubMed/NCBI
69.	Tsujii M: Search for novel target molecules for the effective treatment or prevention of colorectal cancer. Digestion. 85:99–102. 2012. View Article : Google Scholar : PubMed/NCBI
70.	Rothwell PM, Wilson M, Elwin CE, et al: Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 376:1741–1750. 2010.PubMed/NCBI
71.	Long MD, Martin CF, Galanko JA, et al: Hormone replacement therapy, oral contraceptive use and distal large bowel cancer: a population-based case-control study. Am J Gastroenterol. 105:1843–1850. 2010. View Article : Google Scholar : PubMed/NCBI
72.	Baron JA: Statins and the colorectum: hope for chemoprevention? Cancer Prev Res. 3:573–575. 2010. View Article : Google Scholar : PubMed/NCBI
73.	Chan AT and Giovannucci EL: Primary prevention of colorectal cancer. Gastroenterology. 138:2029–2043. 2010. View Article : Google Scholar : PubMed/NCBI
74.	Chu E: An update on the current and emerging targeted agents in metastatic colorectal cancer. Clin Colorectal Cancer. 11:1–13. 2012. View Article : Google Scholar : PubMed/NCBI
75.	Parry S, Win AK, Parry B, et al: Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 60:950–957. 2011. View Article : Google Scholar : PubMed/NCBI
76.	Obermair A, Youlden DR, Young JP, et al: Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 127:2678–2684. 2010. View Article : Google Scholar : PubMed/NCBI
77.	Arber N, Spicak J, Rácz I, et al: Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. Am J Gastroenterol. 106:1135–1346. 2011.PubMed/NCBI
78.	Bolocan A, Ion D, Stoian RV, et al: MAP syndrome (MYH associated polyposis) colorectal cancer, etiopathological connections. J Med Life. 4:109–111. 2011.PubMed/NCBI